Against Ricardian Dogma: A Thoughtful Rebuttal to Sam Rainsy on Trade, Sovereignty, and Comparative AdvantageApril 8, 2025
Sanofi MS drug tolebrutinib misses goal in relapsing disease trials By Reuters Stocks September 2, 2024 By Ludwig Burger (Reuters) – Sanofi (NASDAQ:)’s most advanced multiple sclerosis (MS) drug candidate has missed the main goal of…